Kimberly J Popovits - Net Worth and Insider Trading
Kimberly J Popovits Net Worth
The estimated net worth of Kimberly J Popovits is at least $8 Million dollars as of 2024-04-27. Kimberly J Popovits is the President and CEO of Genomic Health Inc and owns about 116,734 shares of Genomic Health Inc (GHDX) stock worth over $7 Million. Kimberly J Popovits is also the Director of Talis Biomedical Corp and owns about 28,193 shares of Talis Biomedical Corp (TLIS) stock worth over $257,684. Details can be seen in Kimberly J Popovits's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kimberly J Popovits has not made any transactions after 2021-02-17 and currently still holds the listed stock(s).
Transaction Summary of Kimberly J Popovits
Kimberly J Popovits Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kimberly J Popovits owns 6 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) , MyoKardia Inc (MYOK) , and 10x Genomics Inc (TXG) among others .
Click here to see the complete history of Kimberly J Popovits’s form 4 insider trades.
Insider Ownership Summary of Kimberly J Popovits
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals Ltd | 2018-05-23 | director |
| MYOK | MyoKardia Inc | 2020-06-18 | director |
| TXG | 10x Genomics Inc | 2020-03-26 | director |
| ZSPH | ZS Pharma Inc | 2015-12-17 | director |
| ABIO | ARCA biopharma Inc | 2005-07-15 | director |
| TLIS | Talis Biomedical Corp | 2021-02-17 | director |
Kimberly J Popovits Latest Holdings Summary
Kimberly J Popovits currently owns a total of 2 stocks. Among these stocks, Kimberly J Popovits owns 116,734 shares of Genomic Health Inc (GHDX) as of October 8, 2019, with a value of $7 Million and a weighting of 96.64%. Kimberly J Popovits also owns 28,193 shares of Talis Biomedical Corp (TLIS) as of February 17, 2021, with a value of $257,684 and a weighting of 3.36%.
Latest Holdings of Kimberly J Popovits
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2019-10-08 | 116,734 | 63.44 | 7,405,605 |
| TLIS | Talis Biomedical Corp | 2021-02-17 | 28,193 | 9.14 | 257,684 |
Holding Weightings of Kimberly J Popovits
Kimberly J Popovits Form 4 Trading Tracker
According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 4 transactions in Genomic Health Inc (GHDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Genomic Health Inc is the sale of 10,000 shares on October 8, 2019, which brought Kimberly J Popovits around $677,400.
According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 1 transactions in Talis Biomedical Corp (TLIS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talis Biomedical Corp is the acquisition of 353 shares on February 17, 2021, which cost Kimberly J Popovits around $84,800.
Insider Trading History of Kimberly J Popovits
- 1
Kimberly J Popovits Trading Performance
GuruFocus tracks the stock performance after each of Kimberly J Popovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kimberly J Popovits is -57.91%. GuruFocus also compares Kimberly J Popovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kimberly J Popovits within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kimberly J Popovits's insider trading performs compared to the benchmark.
Performance of Kimberly J Popovits
Average Return
-91.62%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -31.39 | -57.91 | -68.4 | -91.62 | -84.26 | -71.62 |
| Relative Return to S&P 500(%) | -32.48 | -63.81 | -81.54 | -103.04 | -86.12 | -80.01 |
Kimberly J Popovits Ownership Network
Ownership Network List of Kimberly J Popovits
Ownership Network Relation of Kimberly J Popovits
Kimberly J Popovits Owned Company Details
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Kimberly J Popovits is the director of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Kimberly J Popovits made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
Kimberly J Popovits Mailing Address
Above is the net worth, insider trading, and ownership report for Kimberly J Popovits. You might contact Kimberly J Popovits via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
